Pfizer posts late-stage trial win for multiple myeloma drug Elrexfio in an earlier line setting
Pfizer (PFE) stock is in focus as the company succeeeds in a late-stage trial for multiple myeloma therapy, Elrexfio in an earlier-line setting. Read more here.